These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3190991)

  • 1. The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine.
    Wooding-Scott RA; Smalley J; Visco J; Slaughter RL
    Br J Clin Pharmacol; 1988 Oct; 26(4):415-21. PubMed ID: 3190991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinidine single dose pharmacokinetics and pharmacodynamics are unaltered by omeprazole.
    Ching MS; Elliott SL; Stead CK; Murdoch RT; Devenish-Meares S; Morgan DJ; Smallwood RA
    Aliment Pharmacol Ther; 1991 Oct; 5(5):523-31. PubMed ID: 1793783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater quinidine-induced QTc interval prolongation in women.
    Benton RE; Sale M; Flockhart DA; Woosley RL
    Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers.
    Min DI; Ku YM; Geraets DR; Lee H
    J Clin Pharmacol; 1996 May; 36(5):469-76. PubMed ID: 8739026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
    Vozeh S; Bindschedler M; Ha HR; Kaufmann G; Guentert TW; Follath F
    Am J Cardiol; 1987 Mar; 59(6):681-4. PubMed ID: 3825912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of quinidine metabolites to electrophysiologic responses in human subjects.
    Kavanagh KM; Wyse DG; Mitchell LB; Gilhooly T; Gillis AM; Duff HJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):352-8. PubMed ID: 2776394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.
    Damkier P; Brøsen K
    Clin Pharmacol Ther; 2000 Aug; 68(2):199-209. PubMed ID: 10976551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
    Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of 3-hydroxyquinidine in patients receiving initial intravenous quinidine gluconate for electrophysiology testing of ventricular tachycardia.
    Ackerman BH; Olsen KM; Kennedy EE; Taylor EH; Chen BH; Jordan D; Ackerman DJ
    DICP; 1989 May; 23(5):375-8. PubMed ID: 2728524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
    Ha HR; Vozeh S; Uematsu T; Guentert TW; Follath F
    Clin Pharmacol Ther; 1987 Sep; 42(3):341-5. PubMed ID: 3621790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
    Vozeh S; Oti-Amoako K; Uematsu T; Follath F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine.
    Edwards DJ; Lavoie R; Beckman H; Blevins R; Rubenfire M
    Clin Pharmacol Ther; 1987 Jan; 41(1):68-73. PubMed ID: 3802708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine, quinidine and their combination in normal man.
    de Mey C; Enterling D; Brendel E; Wesche H
    Eur J Clin Pharmacol; 1988; 34(4):415-8. PubMed ID: 3402527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of quinidine in the rabbit.
    Guentert TW; Huang JD; Oie S
    J Pharm Sci; 1982 Jul; 71(7):812-5. PubMed ID: 7120069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of cimetidine on the metabolism of quinidine: effect on renal clearance.
    Hardy BG; Schentag JJ
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):388-91. PubMed ID: 3220613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
    Rakhit A; Guentert TW; Holford NH; Verhoeven J; Riegelman S
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):315-24. PubMed ID: 6532805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the cardiac electrophysiologic effects of quinidine, 3-hydroxyquinidine and 3-hydroxyhydroquinidine in the anesthesized dog. Study of plasma dose response relations].
    Juliard JM; Heckle J; Jaillon P; Poirier JM; Aubry JP; Cheymol G; Jarreau FX
    Arch Mal Coeur Vaiss; 1983 Jun; 76(6):670-8. PubMed ID: 6414408
    [No Abstract]   [Full Text] [Related]  

  • 19. Itraconazole increases plasma concentrations of quinidine.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinine pharmacokinetics in chronic haemodialysis patients.
    Roy L; Bannon P; Villeneuve JP;
    Br J Clin Pharmacol; 2002 Dec; 54(6):604-9. PubMed ID: 12492607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.